BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18272908)

  • 21. Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
    Martín G; Bellido L; Cruz JJ
    J Clin Oncol; 2007 Aug; 25(23):3559. PubMed ID: 17687168
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
    Kalantari HR
    Br J Cancer; 2009 Oct; 101(7):1222-3; author reply 1224. PubMed ID: 19755985
    [No Abstract]   [Full Text] [Related]  

  • 23. Sunitinib-aggravated hypertension.
    Rivera F; Benounna M; Sánchez de la Nieta MD
    J Hypertens; 2009 Jul; 27(7):1502-3. PubMed ID: 19542988
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sunitinib-induced pyoderma gangrenosum].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2013 Dec; 140(12):841-2. PubMed ID: 24315238
    [No Abstract]   [Full Text] [Related]  

  • 25. Eruptive melanocytic nevi in a patient undergoing treatment with sunitinib.
    Jiménez-Gallo D; Albarrán-Planelles C; Linares-Barrios M; Martínez-Rodríguez A; Báez-Perea JM
    JAMA Dermatol; 2013 May; 149(5):624-6. PubMed ID: 23677103
    [No Abstract]   [Full Text] [Related]  

  • 26. How does sunitinib cause hypothyroidism?
    Hershman JM; Liwanpo L
    Thyroid; 2010 Mar; 20(3):243-4. PubMed ID: 20187779
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiotoxicity associated with sunitinib.
    Hariharan S; Lowry S
    Lancet; 2008 Apr; 371(9620):1244-5; author reply 1245. PubMed ID: 18406854
    [No Abstract]   [Full Text] [Related]  

  • 28. Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.
    Quintyne KI; Neenan T; Casserly L; Gupta R
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
    van den Meiracker AH; Danser AH; Sleijfer S; Kappers MH
    J Natl Cancer Inst; 2011 Oct; 103(20):1557; author reply 1558. PubMed ID: 21862728
    [No Abstract]   [Full Text] [Related]  

  • 30. Sunitinib-induced subungual splinter haemorrhage and acral erythema.
    Nakamura M; Miyachi Y
    Eur J Dermatol; 2008; 18(3):344-5. PubMed ID: 18474471
    [No Abstract]   [Full Text] [Related]  

  • 31. Sunitinib-induced acute hemolysis without hypertension: a case report.
    Jain R; Mathew P; Wood CG; Tannir NM
    Clin Genitourin Cancer; 2008 Sep; 6(2):122-3. PubMed ID: 18824436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy.
    van der Veldt AA; van den Eertwegh AJ; Hoekman K; Barkhof F; Boven E
    Ann Oncol; 2007 Oct; 18(10):1747-50. PubMed ID: 17890217
    [No Abstract]   [Full Text] [Related]  

  • 33. Sunitinib-induced acute psychosis: case report.
    Kunene V; Porfiri E
    Clin Genitourin Cancer; 2011 Sep; 9(1):70-2. PubMed ID: 21729680
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib].
    Rodríguez-Reimúndes E; Perazzo F; Vilches AR
    Medicina (B Aires); 2011; 71(2):158-60. PubMed ID: 21550933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
    Flaig TW; Kim FJ; La Rosa FG; Breaker K; Schoen J; Russ PD
    Invest New Drugs; 2009 Feb; 27(1):83-7. PubMed ID: 18563296
    [No Abstract]   [Full Text] [Related]  

  • 36. Sunitinib-induced hand-foot syndrome in a renal cell carcinoma: a sclerodermatous and rheumatoid arthritis-like case.
    Ohtsuka T
    J Dermatol; 2012 Nov; 39(11):943-4. PubMed ID: 22257303
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of acute adrenal insufficiency unmasked during sunitinib treatment for metastatic renal cell carcinoma.
    Yoshino T; Kawai K; Miyazaki J; Kimura T; Ikeda A; Takaoka E; Suetomi T; Oikawa T; Kojima T; Iwasaki H; Shimano H; Nishiyama H
    Jpn J Clin Oncol; 2012 Aug; 42(8):764-6. PubMed ID: 22581915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sunitinib-related interstitial pneumonia after treatment with temsirolimus: a case of possible recall phenomenon.
    Kushima H; Ishii H; Kadota J
    Int J Urol; 2014 Apr; 21(4):420-1. PubMed ID: 24168290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?
    Winn SK; Ellis S; Savage P; Sampson S; Marsh JE
    Nephrol Dial Transplant; 2009 Feb; 24(2):673-5. PubMed ID: 19039026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
    Rini BI; Tamaskar I; Shaheen P; Salas R; Garcia J; Wood L; Reddy S; Dreicer R; Bukowski RM
    J Natl Cancer Inst; 2007 Jan; 99(1):81-3. PubMed ID: 17202116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.